News

Conducting too many liver tests in one go may cause unnecessary worry, biopsies and costs, according to scientists at the University of Michigan.

Combining the chemotherapy agent Sutent (sunitinib) and immunotherapy may be a promising strategy to fight hepatocellular carcinoma, the most common type of liver cancer, according…

A team of international researchers described a process by which the liver is able to burn up fats that accumulate as a result of non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes. Based on this finding, the researchers developed a cocktail of substances that could trigger this process in the liver.

Consuming fructose, a sweetener used in processed foods and sodas, is an established risk factor for obesity and related metabolic diseases like Type 2 diabetes,…

Tivantinib, an experimental oral inhibitor of the MET receptor, is not better than best supportive care in patients with inoperable hepatocellular carcinoma (HCC) who are intolerant or…

Nanobiotix has named veteran pharmaceutical executive Alain Dostie as its chief operating officer. Among other functions, Dostie will lead the development, manufacturing, market access and…

A team of international researchers identified the genetic cause of a very rare disease seen so far only in a single family living in a remote region of Pakistan.

Patients with cirrhosis (liver damage) may be at a much lower risk of liver cancer than originally assumed, according to results of a recent study…

Diets high in fructose (added sugars) and high levels of uric acid in the blood are more common in obese children and adolescents with non-alcoholic steato-hepatitis (NASH) than in…

Researchers show that the effects of a single high-fat meal alters the sensitivity to insulin and changes liver metabolism in a way that may be…